After a rigorous and fast pace vetting process Alicia Diagnostics (AD) and its dispensing platform were selected to join the 2025 Nucleate Cohort.
“This year’s selection process was our most competitive yet, and your acceptance reflects your incredible potential and hard work. Take a moment to celebrate this milestone— you’ve earned it!” -Yahnell Judah, Co-Activator Director of The Florida Nucleate Team.
Nucleate, a rapidly growing startup comprising 1000+ student trainees from more than 200 institutions globally has recognized the potential of AD’s latest project. Nucleate’s mission is to solve the world’s most pressing biomedical and ecological challenges by enabling the next generation of bio and eco-technology companies. AD is very excited to join them in advancing their initiative.
AD is set to disrupt many industries by increasing the bio-availability of supplements, skin care products, and OTC/Rx drugs in a customizable, repeatable, quantitative, and traceable manner all from a single system. This dispensing “system”, comprised of the dispensing device, our proprietary nano-tech active ingredient filled cartridges, and the companion mobile application, is positioned to be installed in airport terminals, county owned facilities, spas/resorts, cafes, and even bars. The dispensing “system” allows for a value added dose of an active ingredient such as energizers, hydration multipliers, or immune boosters to be added to any beverage without altering the flavor. This same system can be used to customize skin care treatments by tailoring off-the-shelf products to meet the specific needs of each individual customer. AD is also in discussions with diabetic and Alzheimer care clinics to launch systems customized to meet the needs of their patients as well.
Through the Nucleate Activator program AD has added 4 PhD’s and one business strategist to its team. These new team members have helped to fine tune the development, testing, and market viability of this project. The program has provided AD with a multitude of resources, experts, and executives in the bio-medical and pharmaceutical industries to ensure a smooth transition through final development and product launch, with assurance of sustainable market growth.
A special thanks to Carol Nasseh and Cenfluence for bringing this opportunity to AD and for being a critical team member as we explore all of the opportunities this achievement brings to the table.
Alicia Diagnostics Inc. was formed over 35 years ago in partnership with UCF and NASA university projects to bridge the gap between new technology and state-of-the- art medical instrumentation, active ingredient delivery, and food processing techniques. We were founded with the purpose of creating profitable growth while elevating the worldwide standard of medical equipment through the development of high quality, innovative products. Get in touch to be a part of our future growth and success!
www.aliciadiagnostics.com // ssoltani@aliciadiagnostics.com // 407-748-0950
Discover more about Cenfluence:
Cenfluence is a cluster-focused organization that fosters collaboration, innovation, and growth for companies within high-tech sectors, including life sciences, energy+environmental,gaming e-sports+entertainment, learning sciences +human performance and semi-conductors. By connecting members to resources, partnerships, and opportunities, Cenfluence accelerates business development and market expansion while promoting regional economic growth. With a strong commitment to driving innovation, Cenfluence helps its members thrive within a supportive and dynamic ecosystem.
